| Company Name: | Allied HealthCare International, Inc. | | Ticker Symbol: | AHCI | | | WWW Address: | www.twhh.com |
| CEO: | Mr. Alexander Young | | No. of Employees: | 1,160 |
| Common Issue Type: | CS | | Business Description: | The Company is a provider of flexible or temporary, healthcare staffing to the healthcare industry in the United Kingdom.
|
| | | Industry Information: | HEALTH SERVICES - Home Health Care [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 3.89 |  0.0 | - | - | | 3.90 | 3.89 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 169.5 | 43.6 | 0.88 | 0.22 | 0.00 | 20.5 | 0.0 | 3.90 - 2.08 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 3.89 | $ | | PE Ratio - LTM | 20.5 | |
| Market Capitalisation | 169.5 | mil |
| Latest Shares Outstanding | 43.6 | mil |
| Earnings pS (EPS) | 0.22 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 233,689 | $ |
| Effective Tax Rate | 25.9 | % |
| Float | 43.4 | mil |
| Float as % of Shares Outstanding | 99.7 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 0.00 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 0.0 | % |
| EBITDA Margin | 0.0 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 0.0 | % |
| Return on Assets (ROA) | 0.0 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | 0.0 | % |
| Current Ratio | 0.0 | |
| Leverage Ratio (Assets/Equity) | 0.0 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 1.06 | $ |
| Cash pS | 0.92 | $ |
| Book-Value pS | 3.71 | $ |
| Tangible Book-Value pS | 1.12 | $ |
| Cash Flow pS | 0.31 | $ |
| Free Cash Flow pS | 0.13 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.05 | |
| Price/Tangible Book Ratio | 3.47 | |
| Price/Cash Flow | 12.4 | |
| Price/Free Cash Flow | 29.5 | |
| P/E as % of Industry Group | 146.0 | % |
| P/E as % of Sector Segment | 124.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.8 | 102 | 1,417 | 5,215 |
| 4 Weeks | 3.90 | 3.82 | 3.84 | 1.3 | 95 | 1,332 | 25,315 |
| 13 Weeks | 3.90 | 2.41 | 2.49 | 56.5 | 173 | 8,234 | 518,760 |
| 26 Weeks | 3.90 | 2.25 | 2.62 | 48.5 | 163 | 5,497 | 692,593 |
| 52 Weeks | 3.90 | 2.08 | 2.70 | 44.1 | 140 | 3,457 | 867,721 |
| YTD | 3.90 | 2.08 | - | 54.4 | 160 | 4,026 | 817,195 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 3.87 | 3.87 | 3.83 | 3.04 | 2.86 | 0.88 | 0.83 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -4.79 | 63.5 | -2.49 |
| Income | 0.00 | 0.0 | -42.35 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 0.00 | NA | 0.00 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 8.5 | 0.8 | 8.5 |
| Earnings % | 0.0 | -3.2 | -2.4 |
| EPS % | -4.3 | -14.3 | -4.3 |
| EPS $ | -0.01 | -0.01 | -0.01 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 23.43 |
| Current Ratio | 2.5 |
| Quick Ratio (Acid Test) | 2.4 |
| Liquidity Ratio (Cash) | 1.28 |
| Receivables Turnover | 8.4 |
| Average Collection Period | 43 |
| Working Capital/Equity | 29.1 |
| Working Capital pS | 1.02 |
| Cash-Flow pS | 0.33 |
| Free Cash-Flow pS | 0.30 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 4.74 |
| Financial Leverage Ratio (Assets/Equity) | 1.2 |
| Debt Ratio | 19.4 |
| Total Debt/Equity (Gearing Ratio) | 0.01 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 4.3 |
| LT Debt/Total Liabilities | 1.1 |
| Interest Cover | 453.7 |
| Interest/Capital Invested | 0.02 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.86 |
| Tobin's Q Ratio | 0.89 |
| Current P/E Ratio - LTM | 20.50 |
| Enterprise Value (EV)/EBITDA | 9.36 |
| Enterprise Value (EV)/Free Cash Flow | 30.34 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 3.47 |
| Price/Book Ratio - LTM | 1.05 |
| Price/Cash Flow Ratio | 12.4 |
| Price/Free Cash Flow Ratio - LTM | 29.5 |
| Price/Sales Ratio | 0.60 |
| P/E Ratio (1 month ago) - LTM | 20.3 |
| P/E Ratio (26 weeks ago) - LTM | 13.1 |
| P/E Ratio (52 weeks ago) - LTM | 11.7 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 146.0 |
| P/E as % of Sector Segment | 124.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 20.5 |
| PER SHARE FIGURES |
| LT Debt pS | 0.01 |
| Current Liabilities pS | 0.70 |
| Tangible Book Value pS - LTM | 1.12 |
| Book Value pS - LTM | 3.71 |
| Capital Invested pS | 3.53 |
| Cash pS - LTM | 0.92 |
| Cash Flow pS - LTM | 0.31 |
| Free Cash Flow pS - LTM | 0.13 |
| Earnings pS (EPS) | 0.22 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 4.88 |
| Free Cash Flow Margin 5YEAR AVG | 8.89 |
| Net Profit Margin | 3.7 |
| Net Profit Margin - 5YEAR AVRG. | -2.0 |
| Equity Productivity | 1.77 |
| Return on Equity (ROE) | 6.6 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 1.76 |
| Return on Capital Invested (ROCI) | 6.5 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -3.7 |
| Assets Productivity | 1.50 |
| Return on Assets (ROA) | 5.3 |
| Return on Assets (ROA) - 5YEAR AVRG. | -2.8 |
| Gross Profit Margin | 0.0 |
| Gross Profit Margin - 5YEAR AVRG. | 31.8 |
| EBITDA Margin - LTM | 0.0 |
| EBIT Margin - LTM | 0.0 |
| Pre-Tax Profit Margin | 5.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -6.0 |
| Effective Tax Rate | 25.9 |
| Effective Tax Rate - 5YEAR AVRG. | 24.2 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 44 |
| Revenue per Employee | 233,689 |
| Net Income per Employee | 8,669 |
| Average Collection Period | 44 |
| Receivables Turnover | 8.4 |
| Day's Inventory Turnover Ratio | |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 0.58 |
| Assets/Revenue | 0.67 |
| Net Working Capital Turnover | 6.08 |
| Fixed Assets Turnover | 2.35 |
| Total Assets Turnover | 1.5 |
| Revenue per $ Cash | 6.95 |
| Revenue per $ Plant | 30.38 |
| Revenue per $ Common Equity | 1.77 |
| Revenue per $ Capital Invested | 1.76 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 25.4 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 25.9 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
